T
Taeghwan Hyeon
Researcher at Seoul National University
Publications - 613
Citations - 88391
Taeghwan Hyeon is an academic researcher from Seoul National University. The author has contributed to research in topics: Nanoparticle & Catalysis. The author has an hindex of 139, co-authored 563 publications receiving 75814 citations. Previous affiliations of Taeghwan Hyeon include UPRRP College of Natural Sciences & University of Illinois at Urbana–Champaign.
Papers
More filters
Journal ArticleDOI
Ultra-large-scale syntheses of monodisperse nanocrystals.
Jongnam Park,Kwangjin An,Yosun Hwang,Je-Geun Park,Han-Jin Noh,Jae Young Kim,Jae-Hoon Park,Nong-Moon Hwang,Taeghwan Hyeon +8 more
TL;DR: This work is able to synthesize as much as 40 g of monodisperse nanocrystals in a single reaction, without a size-sorting process, and the particle size could be controlled simply by varying the experimental conditions.
Journal ArticleDOI
Recent Progress in the Synthesis of Porous Carbon Materials
TL;DR: A review of the progress made in the last ten years concerning the synthesis of porous carbon materials is summarized in this paper, where several different routes have been used to synthesize mesoporous carbon materials.
Journal ArticleDOI
Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process.
TL;DR: High-temperature (300 degrees C) aging of iron-oleic acid metal complex, which was prepared by the thermal decomposition of iron pentacarbonyl in the presence of oleic acid at 100 degrees C, was found to generate monodisperse iron nanoparticles.
Journal ArticleDOI
Synthesis of monodisperse spherical nanocrystals.
TL;DR: Mechanistic studies have shown that monodisperse nanocrystals are produced when the burst of nucleation that enables separation of the nucleation and growth processes is combined with the subsequent diffusion-controlled growth process through which the crystal size is determined.
Journal ArticleDOI
Inorganic Nanoparticles for MRI Contrast Agents
TL;DR: Recent research has been conducted to develop nanoparticle‐based T1 contrast agents to overcome the drawbacks of iron oxide nanoparticles‐based negative T2 contrast agents.